Computational chemistry — in particular, virtual screening — can provide valuable contributions in hit and lead discovery. However, it seems that there are relatively few examples so far of drug discovery projects in which virtual screening has been the key contributor. This article discusses aspects that could be limiting the potential of virtual screening, and proposes key directions in which significant progress could be made.
